Based on the profound scientific acknowledge and rich research experience, the metabolic disease pharmacological research system. developed by TriApex can provide various metabolic pharmacology research services for clients requiring new drug discovery, including providing scientific ideas and suggestions, participating in research protocol design, implementation of research protocols, analysis and interpretation of experimental data, and collaborative development of new disease models.
TriAepx has an advanced metabolic disease research platform, which can provide intravenous glucose tolerance test (IVGTT), oral glucose tolerance test (OGTT), oral mixed meal tolerance test (OMMTT), glucose gradient test (GGI), glucose clamp test (hyperinsulinemia - glycaemia), etc. At the same time, TriAepx has built a series of top testing technology platforms, including cardiac magnetic resonance imaging technology platform, CT coronary artery imaging technology platform, CT angiography technology (CTA) platform, to meet the requirements for real-time and accurate testing.
TriApex can provide relevant trial services targeting animal models of different metabolic diseases.
Metabolic liver disease model
Body fat distribution
Oral lactose tolerance test
Food/stool energy determination
Body weight measurement
Biomarker detection and gene expression
Metabolic and lipid indicator collection
Biochemical and clinical chemical analysis
Detection of hepatic steatosis based on ultrasound techniques
Evaluation of liver stiffness based on ultrasound elastography
Quantitative analysis of liver fat content, liver biopsy and histological evaluation based on MRI technology
Biomarker detection and analysis